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The recent article by Williams and 
Kriegsfeld (2012) was highly interesting. 
Notably, decreased reproductive function 
with co existent sleep disorders may be seen 
in a number of pathological conditions in 
endocrinology.
For example, patients with obstructive 
sleep apnea (OSA) usually demonstrate 
low levels of free testosterone. These 
decreased levels in OSA patients are 
remarkably independent of the body mass 
index. For instance, the mean free testos-
terone level in patients with severe OSA is 
about 69 pg/ml in comparison to 75 pg/
ml in those without any OSA (Hammoud 
et al., 2011). In fact, a negative relationship 
exists between serum testosterone levels 
and the hypopnea index. Obesity also 
results in increased scrotal temperature 
that can contribute to infertility (Cabler 
et al., 2010). Nocturnal scrotal cooling 
is one treatment option in males with 
oligo-astheno-teratozoospermia.
Overall, a reduced quality of life is seen 
in males with OSA. Testosterone levels are 
improved following the successful treatment 
and management of OSA with Continuous 
Positive Airway Pressure (CPAP) therapy. 
Similar improvements in erectile dys-
function can be seen following successful 
treatment of OSA. A significant decline in 
prolactin levels is also noticed following the 
institution of CPAP therapy thus having a 
further positive impact on male fertility.
Sleep apnea may also be seen with 
decreased reproductive function and 
adjunct obesity in females. Such patients 
may have underlying polycystic ovar-
ian syndrome (PCOS; Randeva et al., 
2012), a condition seen in nearly 7% of 
all females of the reproductive age group 
(Dunaif, 2011). Anti-diabetic agents such 
as metformin have been used successfully 
for  controlling the symptoms of PCOS. 
Similarly, spironolactone has shown con-
siderable promise in the management of 
PCOS. An increased incidence of sleep 
apnea along with decreased reproductive 
function and obesity is also seen in patients 
with Down’s syndrome (Jensen et al., 
2012). Obesity and decreased reproduc-
tion in adjunction with OSA may be seen 
in underlying achondroplasia (Pauli, 1993), 
an autosomal dominant disorder typically 
caused by a mutation in the FGFR3 gene. 
Patients with achondroplasia typically have 
hypotonic, short extremities with a com-
paratively large cranium. Typical facial 
features include mid-face retrusion and 
frontal bossing.
Individuals with acromegaly may have 
coexistent OSA and decreased reproduc-
tive function (Giustina et al., 2003). In fact, 
patients with acromegaly demonstrate a 
close relationship between soft tissue over-
growth in the larynx and OSA. Somatostatin 
analogs such as sandostatin decrease growth 
hormone levels and attenuate upper res-
piratory tract soft tissue overgrowth thus 
improving OSA symptoms in patients 
with acromegaly. Prader–Willi syndrome 
is another pathological condition in which 
obesity and infertility may co-exist with sleep 
disturbances. Daytime hypersomnolence is 
especially seen in patients with Prader–Willi 
syndrome. An increased incidence of OSA is 
also seen in Prader–Willi syndrome.
Females with irregular menstrual cycles 
have almost twice the incidence of sleep 
abnormalities such as “light sleep stages” 
in comparison to those with regular men-
strual cycles (Hachul et al., 2010). Females 
with underlying fibromyalgia also have co 
existent decreased reproductive function 
in addition to a higher incidence of sleep 
abnormalities (Shaver et al., 2006).
The above examples clearly illustrate 
a higher incidence of reproductive dys-
function and sleep disorders in patients 
with the above conditions and the need 
to regularly screen such patients for sleep 
disorders.
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